Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19

Neurological long-term sequelae are increasingly considered an important challenge in the recent COVID-19 pandemic. However, most evidence for neurological symptoms after SARS-CoV-2 infection and central nervous system invasion of the virus stems from individuals severely affected in the acute phase...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Res Pract
Autors principals: Borsche, Max, Reichel, Dirk, Fellbrich, Anja, Lixenfeld, Anne S., Rahmöller, Johann, Vollstedt, Eva-Juliane, Föh, Bandik, Balck, Alexander, Klein, Christine, Ehlers, Marc, Moser, Andreas
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Letter to the Editor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214919/
https://ncbi.nlm.nih.gov/pubmed/34148546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-021-00135-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars